A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer by Ippolito, Joseph E & Piwnica-Worms, David




A fluorescence-coupled assay for gamma
aminobutyric acid (GABA) reveals metabolic
stress-induced modulation of GABA content in
neuroendocrine cancer
Joseph E. Ippolito
Washington University School of Medicine in St. Louis
David Piwnica-Worms
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Ippolito, Joseph E. and Piwnica-Worms, David, ,"A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals
metabolic stress-induced modulation of GABA content in neuroendocrine cancer." PLoS One.9,2. e88667. (2014).
http://digitalcommons.wustl.edu/open_access_pubs/2626
A Fluorescence-Coupled Assay for Gamma Aminobutyric
Acid (GABA) Reveals Metabolic Stress-Induced
Modulation of GABA Content in Neuroendocrine Cancer
Joseph E. Ippolito1,3*, David Piwnica-Worms1,2,4*
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 2 BRIGHT Institute, Washington University
School of Medicine, St. Louis, Missouri, United States of America, 3Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of
America, 4Department of Cancer Systems Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America
Abstract
Pathways involved in the synthesis of the neurotransmitter gamma-aminobutyric acid (GABA) have been implicated in the
pathogenesis of high grade neuroendocrine (NE) neoplasms as well as neoplasms from a non-NE lineage. Using The Cancer
Genome Atlas, overexpression of the GABA synthetic enzyme, glutamate decarboxylase 1 (GAD1), was found to be
associated with decreased disease free-survival in prostate adenocarcinoma and decreased overall survival in clear cell renal
cell carcinomas. Furthermore, GAD1 was found to be expressed in castrate-resistant prostate cancer cell lines, but not
androgen-responsive cell lines. Using a novel fluorescence-coupled enzymatic microplate assay for GABA mediated through
reduction of resazurin in a prostate neuroendocrine carcinoma (PNEC) cell line, acid microenvironment-induced stress
increased GABA levels while alkaline microenvironment-induced stress decreased GABA through modulation of GAD1 and
glutamine synthetase (GLUL) activities. Moreover, glutamine but not glucose deprivation decreased GABA through
modulation of GLUL. Consistent with evidence in prokaryotic and eukaryotic organisms that GABA synthesis mediated
through GAD1 may play a crucial role in surviving stress, GABA may be an important mediator of stress survival in
neoplasms. These findings identify GABA synthesis and metabolism as a potentially important pathway for regulating
cancer cell stress response as well as a potential target for therapeutic strategies.
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Introduction
The neuroendocrine (NE) system is a diffuse network of cells
distributed throughout various tissues and organs that can produce
local or systemic effects on physiology through the secretion of
hormones or neurotransmitters. Although some cells arise from
neural crest, the majority are derived from multipotential
epithelial progenitor cells [1]. Neuroendocrine (NE) carcinomas,
believed to arise from the NE system, occur in virtually all
anatomic locations and display a wide spectrum of phenotypic
behaviors from benign to metastatic [2,3]. For example, ‘‘classic’’
carcinoid tumors or low-grade NE carcinomas are well-differen-
tiated, have a low mitotic index, and resemble NE cell hyperplasia
[2,3], while small cell carcinomas or high grade NE carcinomas
are aggressive and poorly differentiated [4–9]. High grade NE
carcinomas characteristically have numerous areas of necrosis, a
high mitotic index [2,3], and a poor prognosis. Conventional
therapies do not improve patient survival in patients with high
grade NE carcinoma [10].
Adenocarcinomas, which are much more common, arise from
an epithelial origin and display a glandular growth pattern [11].
Interestingly, adenocarcinomas can exhibit NE features charac-
terized molecularly as the expression of gene products associated
with the NE cell lineage. This phenomenon has been demon-
strated in many types of adenocarcinoma, including those from
lung, prostate, and colon, and correlates with tumor aggressive-
ness, metastasis, and shortened survival [12–19]. Specifically, in
the case of prostate cancer, the expression of NE features positively
correlates with metastatic potential and castration-resistant growth
[19–21]. Unfortunately, the biology of NE cells as well as their
contributions to organ homeostasis remain incompletely defined,
in part due to the paucity of these cells in normal organs [22].
Previously, we used a combination of gene expression profiling,
mass spectrometry, and nuclear magnetic resonance spectroscopy
to elucidate a series of metabolic networks implicated in aggressive
NE cancers using a genetically-engineered mouse model of
metastatic prostate NE carcinoma, and a derivative Prostate NE
Carcinoma (PNEC) cell line, wherein the cryptdin 2 promoter
drives expression of oncogenic large T antigen (CR2-TAg) [13,23–
25]. Results of these analyses identified the synthesis and
metabolism of gamma-aminobutyric acid (GABA) derived from
both tricarboxylic acid (TCA) cycle intermediates and polyamines
(collectively referred to as the GABA shunt) as a metabolic
network prominently up regulated in aggressive NE carcinomas
[13].
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Modern specialized instrumentation used for metabolic analy-
ses, such as mass spectrometry (MS) and nuclear magnetic
resonance (NMR) are expensive, require significant training to
operate, and may not be readily available to many academic
laboratories. Classical enzymatic-based metabolite quantitation,
on the other hand, provides a cost-effective, readily accessible,
sensitive means for quantitative analysis of metabolites [26].
Although unable to provide simultaneous information on the
quantities of multiple metabolites, enzymatic quantitation offers
the ability to simultaneously quantitate a given metabolite across
many samples on a high-throughput platform [27–29].
Pyridine nucleotide-based enzymatic assays that couple the
production of NADH or NADPH (collectively referred to as
NAD(P)H) to a biochemical reaction are attractive, as these
reduced nucleotides fluoresce and can therefore be used for
quantitative readout of enzyme activity or metabolite levels.
However, background fluorescence in biological tissues can limit
the sensitivity of NAD(P)H detection [26].
Multiple strategies to enhance the photonic output and improve
the sensitivity of enzymatic reactions have been developed [26,30–
32]. One strategy involves the coupling of NAD(P)H synthesis to
mitochondrial lipoyl dehydrogenase (diaphorase) which activates
chemical substrates for chromogenic or fluorescence assays.
Resazurin is one such compound that can be used for
enzymatically-coupled and cell viability assays [27,33,34]. Here,
we report a novel enzymatic assay for the quantitation of GABA
and successfully use this assay to characterize changes in cellular
GABA in PNEC cells under metabolic stress.
Materials and Methods
Reagents
All chemical and enzymatic reagents were purchased from
Sigma.
Cell Culture
All cell lines routinely tested mycoplasma negative. All cell lines
were cultured at low passage under conventional conditions
according to ATCC protocols in a 95% O2/5% CO2 incubator at
37uC. A self-attaching subclone of the Prostate Neuroendocrine
Cancer (PNEC) cell line [35] was cultured as previously described
[36]. Briefly, DMEM/F12 medium (Invitrogen) was supplemented
with 10% heat inactivated FBS (Gibco), 1% non-essential amino
acids (NEAA, Gibco), B27 serum supplement (Invitrogen), 5 ng/
mL EGF (BDBiosciences), 5 ng/ml bFGF (Sigma), and 15 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer
(Gibco). All cells were grown to a maximum of 75% confluency.
Cells were trypsinized, neutralized with growth media and
passaged. Cell pellets for RNA or biochemical assays were spun
down at 1256g for 5 min at 4uC. Cells were washed with ice cold
phosphate buffered saline, and centrifuged again. Supernatants
were aspirated and pellets snap frozen in liquid nitrogen. All
samples were stored at 280uC until further use.
Evaluation of Survival Curves from The Cancer Genome
Atlas (TCGA)
The cBioPortal for Cancer Genomics [37,38] provided through
The Cancer Genome Atlas Data Portal was used to access and
visualize clinical and gene expression datasets of human prostate
adenocarcinoma [39] and human clear cell renal cell carcinoma
[40]. Only the ‘‘mRNA expression z-scores vs. Normals’’ option
was checked. ‘‘All tumors’’ were selected for the query. RNASeq
data was used for the clear cell carcinoma datasets. Survival curves
were assessed based upon expression of genes within the GABA
shunt. Samples exhibiting increased GAD1 expression (z score.+2
or +3) and decreased GLUL expression (z,–2) were identified and
clinical information exported. Survival curves were constructed
with GraphPad Prism.
Real Time PCR Primer Design
Primers for real time PCR were designed using PrimerBLAST.
GAD1 (NM_000817.2), but not 18S rRNA
(RNA18S5;NR_003286.2), was designed across an intron-exon
junction. Selected primers did not have any predicted off-target
amplification in the human genome. Primer melting temperatures
were designed between 61uC and 63uC. Primers were tested with
PCR from cDNA synthesized from NCI-H660 and LNCaP cell
lines. Amplicons of expected length (GAD1:145 bp; 18S: 182 bp)
were obtained from cDNA preparations and were not evident in
PCR reactions using genomic DNA as a template or water only.
Melt curves and amplification efficiencies of all primer pairs were
performed. The primer sequences are as follows: GAD1 (forward):
59-ATGGGGTTCGCACAGGTCATCC-39, GAD1 (reverse): 59-
TCCATGAGGACAAACACTGGTGCA-39; RNA18S5 (for-
ward): 59-GGGCATTCGTATTGCGCCGC-39, RNA18S5 (re-
verse): 59- GAATAACGCCGCCGCATCGC-39.
Real Time PCR
RNA was isolated from snap frozen cell pellets using the
RNeasy kit (Qiagen). Following RNA extraction, all RNA samples
were aliquoted and stored at 280uC. All RNA samples were
treated with TURBO Dnase (Ambion) for removal of genomic
DNA. All RNA used for quantitative PCR was immediately
reverse transcribed with the iScript kit (BioRad). The purity of the
cDNA was assessed with 18S rRNA PCR amplification of the
cDNA sample and a negative control sample of RNA that lacked
the reverse transcriptase. All samples used for subsequent QPCR
experiments did not have detectable genomic DNA contamina-
tion, as evidenced by a lack of an 18S amplicon following 40 cycles
of the reaction lacking reverse transcriptase. Each sample was
tested in triplicate at 50 ng cDNA. Real-time PCR was performed
with SYBR green master mix (BioRad) and a 100 nM concen-
tration of the specific primer set in a Bio-Rad CFX96 PCR
instrument (95uC for 10 min, then 40 cycles of 95uC for 30 s, 61uC
for 1 min, and 74uC for 1 min). 18S rRNA primers were used as
an internal standard.
Metabolic Stress Experiments
For nutrient deprivation experiments, DMEM/F12 media
lacking glucose, pyruvate, and glutamine (USBiological) was used.
Media was supplemented with the following components: heat
inactivated dialyzed serum with a 10 KDa molecular weight cutoff
(Sigma), 1% non-essential amino acids (NEAA, Gibco), 5 ng/ml
EGF (BDBiosciences), and 5 ng/ml bFGF (Sigma). Glucose and
glutamine (Gibco) were supplemented to the specialized media
when needed. Glucose was added to the medium using standard
DMEM/F12 formulation concentrations of 17.5 mM. Glutamine
was used at 6 mM. Prior to metabolic stress experiments, PNEC
cells were plated at a density of 400,000 cells per well in a 12 well
plate with 1.5 mL of standard growth media. Cells were allowed to
grow for 24 hours. Media was then exchanged for 1.5 mL stress
media. For all pH stress experiments, conventional PNEC growth
media was used without bicarbonate or HEPES buffers and was
modified as follows. For acid stress, 2-(N-morpholino)ethanesulfo-
nic acid (MES), pH 6.5 was added for a final concentration of
20 mM. For conventional pH, HEPES, pH 7.4 was added for a
final concentration of 20 mM and sodium bicarbonate added for a
final concentration of 0.34 g/L. For alkaline stress, tris(hydrox-
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ymethyl)aminomethane (Tris) pH 8.5 was added for a final
concentration of 20 mM and sodium bicarbonate added for a
final concentration of 0.34 g/L. Cells were then incubated in a
humidified chamber without CO2 at 37uC for 24 hours.
Sample Preparation
Sample preparation for the enzymatic assay was modified from
previously described methods [13,26]. For stress experiments,
media was quickly aspirated from the wells and cells were rinsed
with 1 mL PBS. For acid and base stress experiments, wells were
rinsed with saline buffered to the appropriate pH with 20 mM
MES or HEPES as above. Cells were then lysed in 200 mL ice-
cold lysis solution (50 mM sodium hydroxide and 1 mM EDTA)
and gently shaken for 30 sec. An equal volume of 100 mM
hydrochloric acid was then added to acidify the lysate. Plates were
covered with adhesive PCR film seal and incubated in a water
bath at 60uC for 30 minutes to destroy endogenous enzyme
activity as well as endogenous NADH. Following incubation,
plates were briefly centrifuged at 1006g (Allegra 6R; Beckman-
Coulter) to eliminate condensate. The film was removed and
100 mL 400 mM Tris Base was added to each well, for a total
volume of 500 mL lysate in each well (final pH approximately 8).
Lysates were centrifuged at 15,0006g for 5 minutes to pellet debris
and supernatants were collected and frozen at280uC until further
use.
Resazurin-based Assay for GABA and Succinic
Semialdehyde Determination
Following reagent optimization, the mastermix for quantifying
GABA and succinic semialdehyde (SSAL) in samples consisted of
0.063 U/mL GABase, 0.063 U/mL diaphorase, 6.25 mM res-
azurin, 100 mM nicotinamide adenine dinucleotide phosphate
(NADP), 5 mM alpha-ketoglutarate, and 3.125 mM dithiothreitol
(DTT) in 100 mM Tris base, pH 8.8. The mastermix was made
fresh prior to each experiment.
A mastermix for quantifying only SSAL included the above
reagents as well as 50 mM 2-aminoethyl hydrogen sulfate, an
inhibitor of the GABA transaminase component of the GABase
enzyme preparation. The inhibitor was added to the mastermix
for 10 minutes at room temperature prior to the addition of
mastermix to the samples. A fresh preparation of the inhibitor was
prepared prior to all experiments.
Aliquots of sample (10 mL) were added to wells of a 96-well clear
bottom black culture plate (Costar) followed by addition of 90 mL
of mastermix with an electronic multichannel pipette. Two
aliquots of the same sample were used for determination of total
GABA plus SSAL or SSAL alone on the same plate. Unless
otherwise specified, the reaction was conducted at room temper-
ature and was protected from light for 30 minutes. The signal
obtained from resorufin, the fluorescent product of resazurin, was
quantitated using a FLUOstar Optima microplate reader (BMG
Labtech) with a 544 nm excitation/590 nm emission filter set
(gain, 1327; 10 flashes per well). Kinetic analyses were performed
with 1 minute cycles.
The signal for total GABA plus SSAL in each sample was
subtracted from the SSAL alone signal to obtain the signal for
GABA. Standard curves for GABA and SSAL were constructed
for quantitation and were corrected for the reaction blank with
and without the presence of 2-aminoethyl hydrogen sulfate. GABA
and SSAL measurements were normalized to protein in the
lysates, quantitated with the bicinchoninic acid (BCA) assay
(Pierce) using a bovine serum albumin standard curve. Data was
processed with GraphPad Prism. Nutrient and pH stress groups
were analyzed with one way ANOVA and Dunnett post-test for
statistical analysis.
Resazurin-based Assay for Glutamate Determination
An enzymatic assay for the determination of glutamate was
performed as described previously [41]. Briefly, the reaction
components included 10 mM resazurin, 4 U/mL glutamate
dehydrogenase, 0.25 U/mL glutamic-pyruvic transaminase,
100 mM alanine, 0.5 mg/mL NAD+, and 0.5 U/mL diaphorase
in 100 mM Tris-HCl, pH 7.5. 10 mL of the above samples were
added to 90 mL of the reaction mix and assays conducted in the
dark at room temperature. Resorufin signal was measured at 15
minutes. Nutrient and pH stress groups were analyzed with one
way ANOVA and Dunnett post-test for statistical analysis.
NAD(P)H Fluorescence-based GABase Assay
The assay was modified from Passoneau [26]. The mastermix
consisted of 0.08 U/mL GABase, 5 mM alpha-ketoglutarate,
500 mM NADP, 100 mM DTT and 4 mM EGTA in 100 mM
sodium pyrophosphate, pH 8.6. Aliquots of sample (10 mL) were
added to 96-well optical plates (Falcon 353261) followed by 90 mL
of mastermix. The reaction was conducted at room temperature
for 1 hour and measured in a FLUOstar Optima with a 340 nm
excitation/450 nm emission filter set (gain, 2103, 10 flashes per
well).
Western Blotting of Metabolic Enzymes
PNEC cells were plated, stressed, and washed as described
above. 100 ml of ice-cold RIPA buffer (10 mM Tris pH 8.0, 1 mM
EDTA, 0.5 mM EGTA, 140 mM sodium chloride, 0.1% sodium
dodecylsulfate (SDS), 0.1% sodium deoxycholate, and 1% Triton
X-100) containing 1 mM sodium orthovanadate and phenyl-
methylsulfonylfluoride (PMSF) was added. Cells were scraped
from the wells on ice and added to microfuge tubes. Samples were
centrifuged for 10 minutes at 10,0006g at 4uC to remove insoluble
precipitate. Protein was quantitated with the BCA assay as
described above.
A total of 30 mg protein was loaded onto a 4–12% Bis-Tris
polyacrylamide gel (Bolt; Life Technologies) with reducing agent
per manufacturer specifications. The gel was transferred to an
immobilon membrane (Millipore) and blocked with phosphate
buffered saline containing 5% bovine serum albumin and 0.1%
tween–20. The following primary antibodies were used: anti-
GAD1 (MAB5406; Millipore) at 1:5000 dilution, anti-ALDH5A1
(HPA029716; Sigma) at 1:1000 dilution, anti-GLUL (MAB302;
Millipore) at 1:1000 dilution, and anti-ACTB (ab8226; Abcam) at
1:4000 dilution. Primary antibodies were incubated overnight at
4uC. Secondary goat anti-mouse or anti-rabbit horseradish-
peroxidase conjugated antibody (Cell Signaling) was then used at
1:5000 dilution. The same blot was used to examine expression of
all proteins. Following use of each antibody, the blot was stripped
with Western Re-probe (G Biosciences) according to manufacturer
specifications. Blots were developed and imaged using the
WesternBright Quantum detection kit (Advansta).
Enzymatic Assays
PNEC cells were plated, stressed, and washed as described
above. Cells were scraped in 100 ml of ice-cold lysis buffer
(100 mM sodium phosphate, pH 7.0, 20 mM pyridoxal phos-
phate, and 0.1% triton X-100) and repeated a second time for
each well. Samples were briefly sonicated (2–3 seconds) on ice and
subsequently centrifuged for 10 minutes at 10,0006g at 4uC to
remove insoluble material. Prior to sample quantitation, all assays
Stress Modulation of GABA in Neuroendocrine Cancer
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were evaluated for linearity with respect to time and amount of
added lysate. All enzyme activities were normalized to time and
the amount of protein in the lysate. Statistical analyses were
conducted as described above.
Glutamate decarboxylase assay. The method was modi-
fied from an original protocol [42]. The assay buffer contained
100 mM sodium phosphate pH 7.0, 250 mM pyridoxal phos-
phate, 50 mM glutamate, and 0.4% beta-mercaptoethanol. A
reaction blank was conducted for each sample and did not contain
pyridoxal phosphate or glutamate. 50 mL of lysate was added to
50 ml of reaction buffer in a PCR plate and incubated for up to 8
hours at 37uC in a thermocycler without heated lid. The assay was
terminated with the addition of 17 mL of 350 mMHCl and heated
for 30 minutes at 60uC in a thermocycler. The plate was removed
and briefly centrifuged to eliminate condensate. 17 mL of 400 mM
Tris base was added to neutralize the sample and the plate
centrifuged for 10 minutes at 10006g to eliminate protein
precipitate. Wells were then diluted tenfold for measurement of
GABA, the product of the enzymatic reaction, using the GABase-
resazurin assay as described above.
Glutamine synthetase assay. The method was modified
from an original protocol using spectrophotometric determination
of c-glutamyl hydroxamate [43]. The assay buffer contained
50 mM imidazole buffer, pH 6.8, 50 mM hydroxylamine, pH 6.8,
100 mM glutamine, 25 mM sodium arsenate, 0.2 mM adenosine
diphosphate (ADP), and 0.5 mM manganese chloride. A reaction
blank was conducted for each sample and did not contain
arsenate, ADP, or glutamine. 10 mL of lysate was added to 90 ml
of reaction buffer in a PCR plate and incubated for up to 8 hours
at 37uC in a thermocycler without heated lid. The reaction was
terminated with the addition of 100 mL of developing reagent
(0.37 M iron (III) chloride, 0.3 M trichloroacetic acid, 0.6 M
HCl). Samples were centrifuged to remove precipitate and
absorbance measured at 505 nm. Sample absorbance was
calibrated with c-glutamyl hydroxamate standard.
ALDH5A1 (SSADH) assay. The method was modified from
previous protocols [26,44]. The assay buffer contained 100 mM
Tris pH 8.8, 50 mM potassium chloride, 1 mM dithiothreitol,
2.5 mM nicotinamide adenine dinucleotide (NAD), 1.25 mM
SSAL, and 0.02% bovine serum albumin. A reaction blank was
conducted for each sample and did not contain SSAL. 10 mL of
lysate was added to 90 ml of reaction buffer in a PCR plate and
incubated for up to 8 hours at 45uC in a thermocycler without
heated lid. Reactions were transferred to a microplate and the
absorbance of NADH, the enzymatic product, was measured at
355 nm. Sample absorbance was calibrated with NADH standard.
Results
Clinical Implications of the GABA Shunt
We have previously determined with expression analyses that
GABA synthesis is enriched in high grade NE malignancies [13]
and validated the presence of a functional GABA shunt in the
prostate NE cancer (PNEC) cell line using a combination of gene
expression profiling, metabolite and enzyme activity quantitation
[13,25]. GABA can be derived from tricarboxylic acid (TCA) cycle
intermediates and polyamine/cationic amino acid products that
couple GABA metabolism to multiple pathways in cellular energy
metabolism (Fig. 1). In one pathway, GABA is produced by
glutamate decarboxylase 1 (GAD1)-mediated decarboxylation of
glutamate derived from either glutamine or alpha-ketoglutarate
from the TCA cycle. In a second pathway, products of polyamine
and cationic amino acid degradation through putrescine undergo
redox-mediated conversion to GABA. GABA can then be
metabolized by aminobutyrate transaminase (ABAT, GABA-T)
and succinic acid semialdehyde dehydrogenase (ALDH5A1,
SSADH) into succinate for entry into the TCA cycle.
First, to determine if overexpression of GABA shunt enzymes
were detectable in human prostatic malignancies and if overex-
pression correlated with adverse clinical events, we used the
cBioPortal [37,38] of TCGA to interrogate a publicly-available
prostate cancer gene expression dataset and its corresponding
clinical information [39] for cohorts of patients whose cancer
overexpressed components of the GABA shunt. Out of all of the
enzymes listed in Fig. 1, GAD1 was the only gene whose
overexpression was associated with reduced disease-free survival.
We identified a total of 6 patients out of a total of 216 patients
(2.8%) whose cancers displayed GAD1 overexpression with a z-
score greater than +2. Patients with cancers that overexpressed
GAD1 had a median disease free survival time of 19.8 months
versus 110.3 months (p = 0.003) (Fig. 2A). This cohort of patients
had a wide range of prostate serum antigen (PSA) levels ranging
from 3.5 to 40.2 mg/dL, Gleason grades ranging from 3+3 to 4+5,
and staging ranging from T2C to T3B. Although there was only
one documented case of metastatic lymphadenopathy at the time
of surgery, all samples demonstrated extracapsular extension.
Interestingly, decreased expression of glutamine synthetase (GLUL)
that can potentially compete with the GAD1 enzyme for
glutamate was also associated with decreased disease free survival.
A total of 14 patients with z-scores less than –2 were identified with
a median survival of 27.9 months versus 110.3 months (p = 0.006;
Fig. 2B).
As the expression of NE genes has been implicated in castrate-
resistant prostate cancer, specifically with respect to the increased
expression of the NE marker aromatic amino acid decarboxylase
(DDC) in castrate-resistant prostate cancer [21], we determined if
GAD1 mRNA was enriched in human castrate-resistant prostate
cancer. Interestingly, GAD1 mRNA expression was detectable only
in castrate-resistant cell lines (Fig. 2C), with similar expression
levels in the NCI-H660 NE cancer cell line and the PC3 and
DU145 adenocarcinoma cell lines. No detectable expression of
GAD1 was identified in either of the androgen-responsive LNCaP
and LAPC4 cell lines.
Because of a report of GAD1 protein expression in a subset of
renal cell carcinomas [45], we interrogated a recently published
Figure 1. GABA synthetic and metabolic pathways in NE cells.
GLUD: glutamate dehydrogenase; GLS: glutaminase; GLUL: glutamate-
ammonia ligase; GAD1: glutamate decarboxylase; ODC1: ornithine
decarboxylase; ABP1: diamine oxidase; ABAT: GABA transaminase; SSAL:
succinic semialdehyde; ALDH5A1: succinic acid semialdehyde dehydro-
genase; ALDH9A1: aldehyde dehydrogenase; SAT1: spermidine/sperm-
ine N-acetyltransferase.
doi:10.1371/journal.pone.0088667.g001
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study of the clear cell subtype of renal cell carcinomas [40]
provided through the cBioPortal to determine if there were similar
survival characteristics. We identified 39 patients out of a total of
499 patients (8%) whose tumors overexpressed GAD1 mRNA with
a z score greater than +2. This cohort displayed a significantly
decreased overall survival relative to the total clear cell cancer
population with a median survival time of 52.5 months compared
to 80.6 months (p = 0.01). We then isolated a cohort of GAD1
overexpressing tumors (n = 18) with a z-score greater than +3, and
identified a further decrease in overall survival with a median
survival time of 31.1 months compared to 78.4 months (p = 0.002)
(Fig. 2D). There was no significant effect of GLUL mRNA
expression on patient survival in this population.
Assay Development
The potential for GABA to have prognostic significance in
identifying subsets of cancer patients with decreased survival
prompted us to develop an assay for GABA that could be widely
adopted and independent of technically challenging instrumenta-
tion such as mass spectrometry and NMR. The schematic of the
coupled reaction required to quantitate GABA is provided in
Fig. 3. The commercially available ‘‘GABase’’ preparation from
Pseudomonas fluorescens is a combination of ABAT and ALDH5A1
enzyme activities that oxidize GABA through a series of two
reactions into succinate, resulting in reduction of the cofactor
NADP to NADPH. NADPH is then oxidized to NADP by
mitochondrial diaphorase thus coupling the reduction of resazurin
into fluorescent product resorufin. Although ALDH5A1 can use
both NAD+ and NADP as substrates, NADP has conventionally
been used as a cofactor with this enzyme preparation [26].
Assay Optimization
A classical NADPH fluorescence enzyme activity assay [26] was
used as a foundation for optimization of individual components of
a resazurin-based readout of GABA. Each component was titrated
over a range of concentrations, keeping all other components
Figure 2. GABA shunt gene expression in human cancers. A. GAD1 mRNA overexpression in prostate adenocarcinomas correlates with
decreased disease-free survival. Tumors with a GAD1 expression z-score greater than +2 display decreased disease-free survival (median 19.8 months)
relative to tumors that do not have increased GAD1 expression (median 110.3 months; p = 0.002). B. GLUL downregulation in prostate
adenocarcinomas correlates with disease-free survival (median 27.9 months) relative to tumors without GLUL downregulation (median 110.3 months;
p = 0.006). C. GAD1 mRNA expression in prostate cancer cell lines measured with quantitative PCR. GAD1 expression is detectable in castrate-resistant
cell lines NCI-H660, PC3, and DU145, but not androgen-responsive cell lines LNCaP and LAPC4. 18S rRNA was used as an internal standard. DCt is the
difference of the threshold cycle of GAD1 and the threshold cycle of 18S rRNA. ND: Not detected. D. GAD1mRNA overexpression in clear cell renal cell
carcinomas correlates with reduced overall survival. Tumors with a GAD1 z-score.+2 display decreased overall survival (median 52.5 months) relative
to tumors that do not have increased GAD1 expression (median 80.6 months; p = 0.01). Tumors with a GAD1 z-score .+3 display a greater decreased
median survival time (median 31.1 months) relative to the remainder of the tumors (median 78.4 months; p = 0.002).
doi:10.1371/journal.pone.0088667.g002
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constant (Fig. 4). As expected, the assay was sensitive to resazurin,
demonstrating a 5.9-fold increase in signal over background at a
concentration of 6.25 mM. As for the enzymatic components,
there was an 8.6-fold increase in signal relative to background with
0.063 units/mL of GABase, and an 8.9-fold increase in signal over
background with 0.063 units/mL of diaphorase enzyme prepara-
tions. Interestingly, although removal of GABase resulted in
complete loss of signal over background, removal of diaphorase
enzyme from the reaction mix resulted in a signal still 2.7-fold
above background. Upon further analysis, it was found that the
commercial GABase preparation contained NAD(P)H-dependent
resazurin-reducing activity in the absence of GABA, which would
explain this finding (data not shown).
The importance of enzymatic cofactors was also demonstrated
(Fig. 4). NADP, a cofactor for the ALDH5A1 component of the
GABase preparation, added at 100 mM concentration, demon-
strated a significantly increased signal of 9.2-fold relative to
background. Similarly, alpha-ketoglutarate, a cofactor for the
aminobutyrate transaminase component of GABase, demonstrat-
ed 10.1-fold signal to background at a concentration of 5 mM.
Removal of either of these cofactors from the reaction resulted in
complete loss of signal over background.
Dithiothreitol (DTT), a reducing agent used to enhance the
activity of GABase in standard NADPH fluorescence assays [26],
had only a weak effect in the coupled assay. Signal over
background in the absence of DTT was 7.5-fold compared to a
maximum of 8.8-fold signal over background at a concentration of
3.13 mM. Reaction component concentrations with the highest
signal over background were selected for use in the optimized
resazurin assay composition for all future experiments (Fig. 4).
Deconvolution of the Signal Obtained from GABA and
Succinic Semialdehyde
Although the GABase strategy has been used in the direct
enzymatic determination of GABA in biological samples, the
mechanism by which this assay works can also detect succinic
semialdehyde in the sample due to the presence of two enzymatic
activities in the GABase preparation: aminobutyraldehyde trans-
aminase (ABAT) that converts GABA to succinic semialdehyde
(SSAL) and ALDH5A1 that converts SSAL to succinate,
producing NADPH. Therefore, the signal generated from this
reaction mix can in principle arise from a combination of GABA
and SSAL in samples.
We demonstrated this experimentally, by determining the signal
generated from pathway metabolites similar in structure to GABA
including SSAL, glutamate, glutamine, succinate, and butyrate. At
25 mM, GABA and SSAL were the only compounds that
demonstrated signal significantly different from background,
indicating that the resazurin-coupled assay was specific to GABA
and SSAL (Fig. 5A).
To circumvent this potential dual-specificity problem, we used
an inexpensive inhibitor of ABAT, 2-aminoethyl hydrogen sulfate
(ethanolamine-O-sulfate) [46,47]. Addition of this inhibitor to the
mastermix preparation would therefore inhibit ABAT activity in
the GABase preparation, allowing for specific quantitation of
SSAL in the sample. Furthermore, subtraction of signal obtained
in the presence of inhibitor from signal obtained without inhibitor
would result in GABA-specific signal. This methodology has
previously been applied to an enzymatic assay for GABA and
SSAL that uses the less sensitive NAD(P)H fluorescence method
[48].
As expected, we observed a concentration-dependent effect of 2-
aminoethyl hydrogen sulfate on signal obtained from 100 mM
GABA (Fig. 5B). Measurable GABA signal was observed up to
25 mM. For this reason, we used 2-aminoethyl hydrogen sulfate at
a concentration of 50 mM when required to confer specificity in
subsequent experiments.
Mechanics of the Coupled Assay
The kinetics of resorufin formation were analyzed in the
presence of 25 mM GABA and 25 mM SSAL (Fig. 6A). The
formation of resorufin was linear with time through 30 minutes
followed by asymptotic behavior through 120 minutes. Therefore,
a 30 minute time point was selected to generate maximal signal
within the region of linearity for all additional experiments. GABA
or SSAL standards (10 mL) were added to reaction mix (90 mL).
Signal generated from resorufin was linear to 100 mM GABA or
SSAL with an R2 value of 0.997 for GABA and 0.992 for SSAL
(Fig. 6B). Calculation of the ‘‘Z factor’’, a measure of assay
robustness [49], revealed a value of 0.8 for GABA and 0.9 for
SSAL, indicating a robust assay for both metabolites.
The limit of quantitation (LOQ) and the limit of detection
(LOD) were calculated as described previously [50]. The limit of
detection is defined as 3s/S and limit of quantitation is defined as
10s/S where s is the standard deviation of the background and S
is the slope of the standard curve. Using these equations as applied
to our coupled assay, the limit of detection of GABA and SSAL
was 0.78 mM and 0.41 mM, respectively, and the limit of
quantitation was 2.6 mM and 1.4 mM, respectively. For reference,
a NADPH fluorescence assay for GABA was much less sensitive,
revealing a limit of detection of 67 mM and limit of quantitation of
223 mM (Fig. 6C).
Sample Preparation Optimization
We sought to develop an efficient sample preparation protocol
that efficiently lysed tissue, could be conducted in a microplate
format, did not destroy GABA and SSAL, and was compatible
with the enzymatic assay. We modified a previously published
protocol [25,26] that used sodium hydroxide to lyse tissue,
followed by the addition of excess hydrochloric acid, and heating
at 60uC for 30 minutes to destroy endogenous NAD(P)H and
Figure 3. Schematic of the fluorescence-coupled GABA assay.
The GABase preparation, a combination of ABAT and ALDH5A1
enzymes from P. fluorescens converts GABA to succinate through the
conversion of alpha-ketoglutarate to glutamate and NADP to NADPH.
Although NAD or NADP can potentially be used as substrates by
ALDH5A1, NADP is conventionally used as a cofactor for this
preparation. Succinic semialdehyde (SSAL), an intermediate of GABA
metabolism is also metabolized by the GABase preparation. Diaphorase
oxidizes the NADPH and reduces resazurin to fluorescent resorufin.
Application of 2-aminoethyl hydrogen sulfate (2-AEHS), an inhibitor of
ABAT can be used to determine the contribution of SSAL to the total
signal generated from GABA and SSAL in cell lysates.
doi:10.1371/journal.pone.0088667.g003
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Figure 4. Optimization curves for GABase-diaphorase-resazurin coupled assay. Each component of the reaction mix (A–F) was titrated to
determine the optimal concentration to achieve the highest signal to background ratio. The final reaction mix based upon these curves was 6.25 mM
resazurin, 0.063 U/mL GABase, 0.063 U/mL diaphorase, 100 mM NADP, 5 mM alpha-ketoglutarate, and 3.125 mM DTT. Data were obtained in
triplicate.
doi:10.1371/journal.pone.0088667.g004
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enzyme activity that would interfere with the assay, followed by
neutralization with Tris base.
To determine if this sample preparation method was compatible
with GABA and SSAL quantitation, we applied a known
concentration of GABA or SSAL (25 mM final concentration) to
an aliquot of lysed LNCaP cells, a human prostate adenocarci-
noma cell line that contains low GABA shunt activity [25]. Using
lysed LNCaP cells without exogenously applied GABA or SSAL as
comparators, the difference in GABA signal obtained from the two
LNCaP sample groups was compared to 25 mM GABA or SSAL
standards prepared in water and 25 mM GABA or SSAL
standards subjected to the sample preparation method. We
quantitatively recovered the GABA and SSAL standards from
the tissue lysate and demonstrated that GABA and SSAL were
unaffected by the sample preparation method. (Fig. 7).
Assay Limitations
Several biologically-relevant molecules have the potential to
inhibit the assay. Cobalt, commonly used to pharmacologically
simulate hypoxia [51,52] can inhibit diaphorase [53]. Zinc is a
potentially relevant metal in neuronal biology as synaptic zinc can
regulate neuronal excitability and modulate GABA receptors [54–
56]. Both metals showed an inhibitory effect on the assay, but only
at high sample concentrations, with an approximate IC50 of
1000 mM for cobalt and 400 mM for zinc. Oxidative damage from
hydrogen peroxide can inhibit NADH-producing enzymes of the
tricarboxylic acid (TCA) cycle [57], suggesting that peroxide could
inhibit NADH production in the coupled assay. However, only a
weak effect of peroxide was observed with approximately 30%
inhibition at 1 mM concentration in the sample (Fig. 8A).
Given the presence of labile components in the reaction mix, we
investigated the stability of the reaction mix at two temperatures,
4uC and room temperature (RT), over a course of 24 hours. The
reaction mix was more stable when kept at 4uC compared to RT,
but still decayed over time, retaining only 66% of its activity at 6
hours and demonstrating complete loss of activity by 24 hours
following preparation (Fig. 8B). For this reason, fresh reaction
mix was prepared prior to each assay.
Validation of the Assay
The correlation between GAD1 mRNA overexpression and
decreased disease-free survival in prostate adenocarcinoma and
overall survival in clear cell renal cell carcinoma prompted us to
examine the potential role of GAD1 in NE metabolism. Although
not documented previously in cancer, GAD activity is increased in
other organisms such as plants and bacteria in response to biotic
and abiotic stressors [58], such as acidity. In addition, evaluation
of the GABA shunt pathway demonstrates that glutamate, the
substrate for GAD1, may be derived from alpha-ketoglutarate
from the TCA cycle or alternatively from glutamine. This
suggested that perturbations to the extracellular environment,
specifically pH changes and nutrient deprivation, could modulate
the concentration of GABA in cancer cells.
The robust concentration of GABA in PNEC cells coupled with
previous findings that GABA shunt components, specifically
GAD1, are enriched in PNEC cells relative to other prostate
adenocarcinoma cells [25] prompted us to use this cell line to
investigate environment stress-induced modulation of GABA.
We first quantitated GABA in the PNEC cell line following 24
hours of glucose or glutamine deprivation. Relative to control (i.e.,
conventional media with dialyzed serum), there was no statistically
significant difference in the amount of GABA in glucose-deprived
PNEC cells (1137 versus 1182 pmol GABA/mg protein, respec-
tively). However, glutamine deprivation significantly decreased
cellular GABA (390 pmol GABA/mg cellular protein) relative to
control. Interestingly, levels of SSAL were relatively unaffected by
these stresses, with the exception of glucose deprivation. Glucose
deprivation induced mildly increased SSAL (21.3 pmol SSAL/mg
Figure 5. Specificity of the GABase assay. A. Metabolic standards (25 mM) were added to reaction mix and kinetically observed for 30 minutes.
When compared to metabolites similar in chemical structure, GABA and SSAL are the only compounds that generate measurable signal in the
coupled assay. Note break in scale to visualize residual activities. ND: No signal detected over background. Fluorescence signal is measured in
arbitrary units (A.U.) and is corrected against the sample blank. B. Inhibition curve of 2-aminoethyl hydrogen sulfate, an inhibitor of the GABA
transaminase (ABAT) component of the GABase preparation. At concentrations equal to or greater than 25 mM, the resorufin signal from GABA is
completely abolished, allowing for the NADPH (hence resorufin signal) produced by succinic aldehyde dehydrogenase (ALDH5A1) component of the
GABase preparation to be specific for succinic semialdehyde (SSAL). Data were obtained in triplicate and normalized to signal in the absence of
inhibitor.
doi:10.1371/journal.pone.0088667.g005
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protein) compared to control (16.7 pmol SSAL/mg protein), just
achieving statistical significance (p,0.05) (Fig. 9).
Besides quantitating GABA as well as its downstream metab-
olite, SSAL, under stresses, we also measured the upstream
metabolite, glutamate, in PNEC cells under these same stresses.
We employed a published resazurin-based enzymatic assay for the
detection of glutamate [41] to determine glutamate levels in
stressed PNEC cells. Interestingly, relative to control, glutamate
levels were significantly decreased by glucose deprivation (316
versus 209 pmol/mg protein, respectively) and most pronounced
by glutamine deprivation (71 pmol/mg protein) (Fig. 9).
Enzymes within the GABA shunt have different pH optima
[26]. For example, mammalian GAD1 has an optimal pH range of
6–7 and mammalian ABAT and ALDH5A1 have an optimal pH
range between pH 8–9. This suggested that acidic conditions
would favor the synthesis of GABA and, conversely, alkaline
conditions would favor the metabolism of GABA. Following 24
hours of exposure to an environmental pH of 6.5, GABA content
in PNEC cells was significantly elevated relative to a pH of 7.5
(1142 versus 870 pmol/mg protein). Conversely, GABA content
was significantly decreased in PNEC cells exposed to pH 8.5
(521 pmol/mg protein) (Fig. 9). Despite these changes in GABA,
there were no statistically different changes in levels of SSAL
relative to control (Fig. 9).
Glutamate levels in PNEC cells under pH stress were also
measured. Although there was no significant difference in the
Figure 6. Mechanics of the GABase assay. A. Representative
kinetics for the coupled GABase assay using 25 mM GABA. Plateau
kinetics are seen after 30 minutes. The kinetic curve represents an
average of triplicate measurements. B. Linearity of the assay. GABA and
SSAL standards (10 mL) at the concentrations indicated were added to
reaction mix (90 mL) and measured after 30 minutes. The limit of
detection for the assay was 0.78 mM GABA and 0.41 mM SSAL. The limit
of quantitation was 2.6 mM GABA and 1.4 mM SSAL. The Z’ factor for the
assay was 0.8 for GABA and 0.9 for SSAL. C. Standard curve of [GABA]
using a conventional NADPH fluorescence assay. This assay demon-
strated lower sensitivity than the coupled resazurin assay when carried
out under optimum conditions in an optical plate. The limit of detection
for the assay was 67 mM. The limit of quantitation for the assay was
223 mM. The Z’ factor for the assay was 0.9. Fluorescence signal is
measured in arbitrary units (A.U.) and is corrected against the sample
blank. Data were obtained in triplicate.
doi:10.1371/journal.pone.0088667.g006
Figure 7. Effects of sample preparation on GABA and SSAL
stability and recovery. 25 mM of GABA or SSAL standard was treated
with the sample preparation protocol consisting of 50 mM sodium
hydroxide followed by heating at 60uC for 40 minutes in excess 50 mM
HCl and then neutralization with 400 mM Tris base. There was no
significant difference in signal obtained from a 25 mM GABA or SSAL
standard versus 25 mM GABA or SSAL treated with the sample
preparation technique. To test recovery of GABA and SSAL from tissue,
GABA or SSAL standard was added to the LNCaP prostate cancer cell
sample at a final concentration of 25 mM and subjected to the sample
preparation protocol. The signal recovered from the sample was
subtracted from the signal obtained from an identical tissue sample
without added standard, demonstrating quantitative recovery of GABA
and SSAL from tissues using this technique. Fluorescence signal was
measured and all data normalized to untreated standards. Data were
obtained in triplicate.
doi:10.1371/journal.pone.0088667.g007
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amount of glutamate in PNEC cells in pH 6.5 versus pH 7.5 (158
versus 193 pmol/mg protein, respectively), there was significantly
elevated glutamate at pH 8.5 (458 pmol/mg protein) (Fig. 9).
To explain these changes in PNEC cell metabolites, we
investigated enzymatic activity of three key components involved
in glutamate, GABA, and SSAL metabolism. In addition to
modifying our novel assay to measure GABA produced by GAD
activity, we also utilized conventional enzymatic assays for GLUL
and ALDH5A1.
There was no significant difference in GAD activity following
glucose or glutamine deprivation (Fig. 10). Of note, there was a
trend toward increased GAD activity that could correlate with the
significantly increased SSAL levels following glucose deprivation
(188.4 versus 142.5 pmol GABA/hr/mg protein). ALDH5A1
activity, similarly, did not demonstrate any significant differences
in activity. However, the most notable differences were seen in
GLUL activity. Interestingly, glucose deprivation significantly
increased GLUL activity (20.27 versus 9.88 pmol c-glutamyl
hydroxamate/hr/mg protein). Glutamine deprivation, as expected,
had the most dramatic increase in GLUL activity (47.5 pmol c-
glutamyl hydroxamate/hr/mg protein). We then assessed protein
expression levels of these enzymes to correlate with their activities.
No definite changes in expression were seen with GAD1 or
ALDH5A1. However, GLUL expression was increased in both
glucose and glutamine deprivation (Fig. 10D).
The effects of pH on GAD activity were more pronounced.
Interestingly, acidic pH significantly increased GAD activity (344
versus 272 pmol GABA/hr/mg protein). Conversely, alkaline pH
significantly decreased GAD activity relative to physiologic pH
(185 pmol GABA/hr/mg protein). The effect of pH on GLUL
activity was different, however. Although acidic pH increased
GLUL activity (16.93 versus 8.15 pmol c-glutamyl hydroxamate/
hr/mg protein), alkaline pH also increased GLUL activity
(11.74 pmol c-glutamyl hydroxamate/hr/mg protein). The effect
of pH on ALDH5A1 activity was different altogether, with
statistically-unchanged activity in acidic versus physiologic pH
(2.72 versus 2.66 nmol NADH/hr/mg protein) as well as alkaline
pH (2.36 nmol NADH/hr/mg protein). Herein, protein expression
correlated with enzyme activity. GAD1 expression was increased
in acidic pH and decreased in alkaline pH, GLUL expression was
increased both in acidic and alkaline pH, and ALDH5A1 was
unchanged (Fig. 11).
Discussion
Using previously published datasets characterizing gene expres-
sion in prostate and renal cancers [39,40], a potentially deleterious
effect of GAD1 overexpression and GLUL underexpression on
patient survival was identified. Both enzymes use glutamate and
therefore compete for the same substrate, suggesting the presence
of a metabolic antagonism where glutamate conversion to GABA
over glutamine is favored in the context of cancers associated with
poorer outcomes. Furthermore, the unique overexpression of
GAD1 mRNA in a select cohort of castrate-resistant prostate
cancer cell lines was revealed. However, the clinical significance of
GAD1 in castrate-resistant prostate cancer remains to be clarified,
as the number of GAD1-overexpressing prostate cancers identified
in the public databases were small and could not be accurately
correlated with castrate-resistant disease. Nonetheless, increased
protein expression of the NE enzyme, dopa decarboxylase (DDC;
E.C. 4.1.1.28) correlates with castrate-resistant disease [21],
further supporting a NE program associated with castrate-resistant
prostate cancer. These analyses need to be expanded to larger
patient populations and further evaluated with rigorous immuno-
histochemical and metabolomics methods to further define the
prognostic significance of GAD1 and its related pathway
components on patient survival and disease recurrence. Our
results are further supported by studies documenting the
proliferative effects of GABA on cancer cells, the expression of
GAD1, and the expression of GABA receptors in multiple cancers
throughout the body [59–62].
The GABA shunt is conserved in prokaryotes and eukaryotes
and is upregulated in the context of multiple stresses. For example,
glutamic acid decarboxylase is widely implicated in the survival of
prokaryotes and plants in acidic environments [58,63–67].
However, the mechanisms by which glutamic acid decarboxylase
allows organisms to survive acidic stress remains unclear. The
apparent role of the GABA shunt in the evasion of environmental
stresses to promote survival in other organisms is intriguing as such
Figure 8. Limitations of the GABase assay. A. Inhibitors of the GABase assay. Titrations of potential inhibitors of the GABase assay were carried
out and signal was measured after 30 minutes. The assay demonstrated inhibition by the heavy metals cobalt (IC50 = 1 mM) and zinc (IC50 = 400 mm)
at high concentrations. There is weak inhibition by hydrogen peroxide at high sample concentrations (1 mM). Data were obtained in triplicate. B.
Reaction mix decay kinetics. Following preparation of complete reaction mix, the mix was stored in the dark at either 4uC or 25uC. Following the times
listed, the reaction mix was added to a fixed concentration of GABA standard. Signal obtained at different time points was normalized to the signal
obtained at time zero. Data were obtained in triplicate.
doi:10.1371/journal.pone.0088667.g008
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Figure 9. Quantitation of GABA, SSAL, and glutamate in PNEC cells following 24 hours of pH stress and nutrient deprivation. The
effects of 24-hour glucose and glutamine deprivation on A. GABA, B. SSAL, and C. glutamate levels in PNEC cells were measured. Nutrient
deprivation experiments were performed in substrate-deficient DMEM/F12 media containing dialyzed fetal calf serum supplemented with 6 mM
glutamine and/or 17.5 mM glucose for 24 hours. The effects of 24-hour pH stress at pH 6.5 and 8.5 relative to physiologic pH 7.4 on D. GABA, E.
SSAL, and F. glutamate levels in PNEC cells were measured. Metabolite levels in the cell lysates was assayed and normalized to total cellular protein. *
Significance relative to control (p,0.05). Data represents quadruplicate measurements.
doi:10.1371/journal.pone.0088667.g009
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stresses are also significant in the cancer cell microenvironment
and may therefore be involved in the ability of cancer cells to
survive stress.
Many studies have been conducted on the effects of the cancer
microenvironment on tumor physiology. For example, acidity has
been demonstrated to drive metastasis [68], while alkalization of
the tumor microenvironment with sodium bicarbonate reduces
metastasis [69–71]. Our findings suggest an interplay between the
cancer microenvironment, cancer metabolism, and metastatic
potential of cancer cells. It has been documented previously that
GAD1-mediated GABA synthesis and signaling through GABA-B
receptors facilitate the expression of matrix metalloproteinases and
invasion of prostate cancer cells [72]. We suggest that activity of
the GABA shunt, at least in prostate cancer cells, may represent a
metabolic pathway through which the microenvironment may
stimulate metastasis and may also represent a mechanism by
which bicarbonate therapy acts to reduce metastasis.
Herein, we demonstrated that alterations in extracellular pH
can modulate levels of the GABA shunt metabolites glutamate and
GABA through modulation of the expression and activity of the
enzymes GAD1 and GLUL. Under acidic conditions, GAD1
protein and activity are increased in PNEC cells correlating with
increased GABA concentration. Interestingly, GLUL protein
levels and activity are also increased under acidic pH. Despite
the increased activity of both of these enzymes involved in
glutamate metabolism, there are no statistically significant
differences in glutamate concentration under acidic pH. These
findings could represent a complex manifestation of metabolic flux
through additional metabolic as well as protein synthetic pathways
in which glutamate is involved.
The effects of alkalinity on the GABA shunt are equally as
intriguing. Exposure to an alkaline pH of 8.5 is met with decreased
GAD1 activity as well as a decrease in GABA and an increase in
glutamate concentration. Although these changes in metabolite
concentration are expected for decreased GAD1 activity, there is
also an increase in GLUL activity under alkaline pH. Of note,
protein levels of GLUL in alkaline pH were higher compared to
acidic pH, despite similar enzyme activity. This could be due to
the presence of endogenous enzymatic inhibitors in complex cell
lysate or could represent metabolic variability among passages in
cell culture, although all cells used in this study were of low culture
number. It is currently unclear if the mechanism underlying
upregulation of GLUL or its predicted increase in glutamine
concentration under alkaline pH is the same as that under acidic
Figure 10. Enzyme activity measurements of GAD1, GLUL, and ALDH5A1 in PNEC cells following nutrient deprivation. The effects of
24-hour glucose and glutamine deprivation on A. GAD1, B. GLUL, and C. ALDH5A1 levels in PNEC cells were measured. D. Protein expression of
enzymes correlate with enzyme activities. Beta actin (ACTB) is provided as a loading control. Nutrient deprivation experiments were performed as
described above. Enzyme activity in the cell lysates was assayed and normalized to reaction time and total cellular protein. * Significance relative to
control (p,0.05). Data represents quadruplicate measurements.
doi:10.1371/journal.pone.0088667.g010
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pH. The significant increase in glutamate concentration under
alkaline, but not acidic pH further underscores the potential for
complex metabolic fluxes of glutamate, glutamine, and GABA
during pH stress. At this point, we hypothesize that the decrease in
GABA under alkaline pH may be related to a combination of
substrate competition from increased GLUL as well as decreased
GAD1 activity.
The mechanism underlying relatively stable expression of
ALDH5A1 under acid and alkaline stress as well as its known
regulation by the cellular redox state [73] suggests that the
metabolism of GABA into succinate may be more dependent upon
post-translational regulation than gene expression. Although the
activity of ALDH5A1 is optimal at a pH of 8–9 [26], there was no
evidence of significantly different changes in enzyme activity in
PNEC cell lysates. Although factors such as extracellular pH,
pCO2, bicarbonate, and lactate can directly affect intracellular pH
[74,75], it is currently unclear if ALDH5A1 activity is directly
modulated by alterations in intracellular pH. In addition, the role
of ABAT in GABA metabolism remains to be elucidated.
Unchanged concentration of SSAL under pH stress may also
represent the effect of complex metabolic fluxes, specifically from
carbons through the urea cycle arm of the GABA shunt [13].
The relative contributions of glucose and glutamine to GABA
synthesis in cancer cells are incompletely understood. However,
general contributions of glucose and glutamine to cancer cell
metabolism have been widely documented [76]. Of note,
glutamine is an alternative substrate to glucose for the synthesis
of nucleotides and lipids and a source for ATP [77,78]. In
addition, the contributions of glutamine metabolism toward
cancer cell stress survival have been studied to some extent with
evidence that cancer cell survival in hypoxia may be dependent on
glutamine and glutamate metabolism [79]. Despite no significant
change in GAD1 expression or activity following glutamine
deprivation, we identified decreased glutamate and GABA,
correlating with increased GLUL activity, as a potential mecha-
nism to increase cellular stores of glutamine. This further supports
a potential metabolic antagonism between GLUL and GAD1 that
we also identified under alkaline conditions and suggested from the
survival analysis. A trend toward decreased SSAL and ALDH5A1
activity following glutamine deprivation suggests decreased flux
through the GABA shunt as a result of glutamine deprivation.
These findings provide further support for glutamine deprivation
as an anticancer therapy to decrease GABA synthesis.
Although glucose deprivation did not result in significant
changes in GAD1 expression or activity, there was also a potential
Figure 11. Enzyme activity measurements of GAD1, GLUL, and ALDH5A1 in PNEC cells following pH stress. The effects of 24-hour acid
and alkaline stress on A. GAD1, B. GLUL, and C. ALDH5A1 levels in PNEC cells were measured. D. Protein expression of enzymes correlates with
enzyme activities. Beta actin (ACTB) is provided as a loading control. Enzyme activity in the cell lysates was assayed and normalized to reaction time
and total cellular protein. * Significance relative to control (p,0.05). Data represents quadruplicate measurements.
doi:10.1371/journal.pone.0088667.g011
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trend toward increased GAD1 activity as well as significantly
increased SSAL, suggesting that flux through the GABA shunt is
maintained or potentially increased during glucose deprivation. Of
note, our glucose deprivation experiments were conducted in the
absence of exogenous pyruvate, which could potentially act as
carbon sources for the TCA cycle. It is possible that the GABA
shunt in glucose deprivation may represent a mechanism to
produce NADH through the activity of ALDH5A1 and supply
carbons to the TCA cycle, presumably through glutamine and
potentially the urea cycle, although this remains to be demon-
strated with more complex metabolic flux analysis. Increased
GLUL activity in glucose deprivation is likely a manifestation of
depleted glutamine reserves in cell culture media (used at 6 mM in
these experiments) further supporting the need for glutamine as a
carbon source for cells in the absence of glucose.
In summary, we have described a new fluorometric assay that
has provided a first glimpse into how pH and nutrient stress
modulate GABA in prostate NE cancer cells. This presents a novel
regulatory mechanism by which cancer cells can respond to
environmental stresses. This assay can be widely adapted into
single microplate or high throughput formats to measure GABA
content in multiple samples under multiple conditions, treatments,
or time points.
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